Joinn Laboratories(China)Co.,Ltd. (SHA:603127)
45.18
-1.29 (-2.78%)
Sep 1, 2026, 3:00 PM CST
SHA:603127 Revenue
Joinn Laboratories(China)Co.,Ltd. had revenue of 387.68M CNY in the quarter ending June 30, 2026, with 1.69% growth. This brings the company's revenue in the last twelve months to 1.69B, down -7.87% year-over-year. In the year 2025, Joinn Laboratories(China)Co.,Ltd. had annual revenue of 1.66B, down -17.87%.
Revenue (ttm)
1.69B
Revenue Growth
-7.87%
P/S Ratio
18.53
Revenue / Employee
639.06K
Employees
2,649
Market Cap
31.37B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.66B | -360.71M | -17.87% |
| Dec 31, 2024 | 2.02B | -358.15M | -15.07% |
| Dec 31, 2023 | 2.38B | 108.52M | 4.78% |
| Dec 31, 2022 | 2.27B | 751.29M | 49.54% |
| Dec 31, 2021 | 1.52B | 440.78M | 40.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Dian Diagnostics Group | 9.93B |
| Hangzhou Tigermed Consulting | 7.29B |
| Shanghai Runda Medical Technology | 6.72B |
| Guangzhou Kingmed Diagnostics Group | 5.92B |
| BGI Genomics | 3.86B |
| Maccura Biotechnology Co.Ltd | 2.13B |
| Beijing Strong Biotechnologies,Inc. | 1.37B |
| Shanghai Labway Clinical Laboratory | 1.28B |